Baxter International Inc
SWB:BTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Baxter International Inc
SWB:BTL
|
US |
Intrinsic Value
The intrinsic value of
Baxter International Inc (BTL) under the Base Case is 24.84 EUR per share.
Compared with the current market price of 21.77 EUR, the stock appears
Undervalued by 12% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Baxter International Does
Baxter International makes medical products that hospitals and other care providers use to treat patients every day. Its lineup includes IV fluids, infusion pumps, drug-delivery systems, nutrition therapies, and disposable supplies that help doctors and nurses give medicines, fluids, and nutrition safely and consistently.
- Headquarters
- United States of America US
- Employees
- 37 500
- IPO date
- May 15, 1961
Baxter International has a narrow economic moat
Replacing equipment tied into hospital records and daily care routines takes money, staff training and careful testing. This gives Baxter a lasting foothold where hospitals already use its connected pumps, beds and communication systems, rather than protecting every product it sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Baxter International Inc
Earnings Waterfall
Baxter International Inc
The intrinsic value for
Baxter International Inc (BTL) under the Base Case is 24.84 EUR.
Compared with the current market price of 21.77 EUR, the stock appears Undervalued by 12% .